If you put aside the “breakthroughs”, “remarkables” and heralding new eras, the key is the statement that this all needs confirming by a randomised controlled trial with placebo which I suppose means Lu plus Nox drug vs Lu plus placebo.
In other words this ain’t coming to a regulatory agency any time soon.
The wide confidence interval for survival 9-30 months shows how imprecise the reported survival estimate is. No problems with that, just all down to being small trial. promising at best, But you don’t usually herald a new era with something like this.
- Forums
- ASX - By Stock
- NOX
- Ann: LuPIN Survival Outcome Confirmed by Conference Presentation
Ann: LuPIN Survival Outcome Confirmed by Conference Presentation, page-7
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add NOX (ASX) to my watchlist
|
|||||
Last
6.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $19.28M |
Open | High | Low | Value | Volume |
6.6¢ | 6.6¢ | 6.6¢ | $336 | 5.089K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 14893 | 6.7¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
7.9¢ | 12000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 14893 | 0.067 |
1 | 50000 | 0.066 |
1 | 7703 | 0.065 |
1 | 100000 | 0.064 |
3 | 47786 | 0.061 |
Price($) | Vol. | No. |
---|---|---|
0.079 | 12000 | 1 |
0.080 | 12099 | 2 |
0.081 | 22345 | 2 |
0.083 | 40000 | 1 |
0.090 | 25689 | 3 |
Last trade - 11.03am 01/07/2024 (20 minute delay) ? |
Featured News
NOX (ASX) Chart |
The Watchlist
I88
INFINI RESOURCES LIMITED
Charles Armstrong, CEO
Charles Armstrong
CEO
SPONSORED BY The Market Online